Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Shanghai Institute of Materia Medica (SIMM) has purchased an online subscription to the Instem's Provantis preclinical software solution suite for use across the areas of general toxicology, clinical pathology and pathology.
Subscribe to our email newsletter
Instem claimed that Provantis is a preclinical research technology solution that is easy to use and will offer dual language operation and protocol-driven automation that will produce quality study output in greatly reduced timescales.
Instem CEO Phil Reason said that as the primary participant in the newly established Research Center for Modernisation of Traditional Chinese Medicine, they were honored that SIMM has chosen Instem’s Provantis software to automate their research laboratories.
SIMM is expected to be using Instem’s SaaS (Software-as-a-Service) model offering simpler, cost effective ways to provide software functionality, maintenance, and support over the Internet.